Maysam Alimohamadi Selected Research

Maysam Alimohamadi Research Topics

9	Neoplasms (Cancer) 12/2019 - 10/2011
4	Glioma (Gliomas) 01/2022 - 08/2016
2	Neurilemmoma (Schwannoma) 04/2016 - 12/2014
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 05/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Ependymoma 12/2020
1	Confusion (Bewilderment) 10/2020
1	Brain Edema (Cerebral Edema) 10/2020
1	Epilepsy (Aura) 07/2019
1	Stroke (Strokes) 01/2018
1	Prolactinoma (Prolactinomas) 01/2018
1	Pituitary Apoplexy 01/2018
1	Paraganglioma (Paragangliomas) 04/2016
1	Hyponatremia 01/2016
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2016
1	Facial Paralysis (Facial Palsy) 08/2015
1	Glaucoma 07/2015
1	Giant Cell Arteritis (Horton Disease) 07/2015
1	Fibrosis (Cirrhosis) 12/2014
1	Pituitary Neoplasms (Pituitary Adenoma) 07/2014
1	Adenoma (Adenomas) 07/2014
1	Growth Hormone-Secreting Pituitary Adenoma 07/2014
1	Pancreatitis 08/2013
1	Neurofibromatoses (Neurofibromatosis) 10/2011
1	Brain Neoplasms (Brain Tumor) 10/2011

2	Growth Hormone (Somatotropin)IBA 07/2019 - 07/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 05/2021
1	DiureticsIBA 10/2020
1	Mannitol (Osmitrol)FDA LinkGeneric 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020
1	Hemoglobins (Hemoglobin)IBA 12/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2019
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2018
1	Cabergoline FDA LinkGeneric 01/2018
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2018
1	Phenobarbital (Luminal)FDA Link 04/2016
1	ElectrolytesIBA 01/2016
1	CollagenIBA 12/2014
1	Biomarkers (Surrogate Marker)IBA 07/2014
1	ProlactinIBA 07/2014
1	Biological ProductsIBA 10/2011